Centene Stock Forecast for 2022 - 2025 - 2030

Updated on 12/09/2022

Stock Rating
12
Price Target
$100.00
Consensus
Outperform
Upside
15.62%
Analysts
6
Stock Rating
12
Upside
15.62%
Analysts
6
Price Target
$100.00

Centene Stock Forecast and Price Target

If Centene's stock price reached the average yearlong target of $100.00 given by six well-known analysts in recent months, there would be a potential upside of approximately 15.62% from its last closing price in December, 2022. This potential increase is based on a high estimate of $115.00 and a low estimate of $87.00. If interested in CNC stock, you may also want to consider its competitors.

$100.00

15.62% Upside

Outperform
Outperform

Centene Fair Value Forecast for 2022 - 2025 - 2030

Centene's Price has seen impressive growth In the last three years, rising from $51.79 to $75.34 – a growth of 45.48%. In the next year, analysts believe that Fair Value will reach $79.15 – an increase of 5.05%. For the next nine years, the forecast is for Fair Value to grow by 172.23%.

2022 Fair Value Forecast
$79.15
2023 Fair Value Forecast
$92.32
2024 Fair Value Forecast
$111.92
2025 Fair Value Forecast
$124.36
2026 Fair Value Forecast
$137.23
2027 Fair Value Forecast
$151.57
2028 Fair Value Forecast
$168.10
2029 Fair Value Forecast
$186.53
2030 Fair Value Forecast
$205.11
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
UNH Stock Forecast UnitedHealth Group Outperform 16
$547.92 Buy/Sell $579.33 9.05%
ANTM Stock Forecast Anthem Buy 13
$529.12 Buy/Sell $544.63 7.92%
CI Stock Forecast Cigna Outperform 13
$333.50 Buy/Sell $295.91 7.05%
HUM Stock Forecast Humana Outperform 15
$547.36 Buy/Sell $504.43 13.27%
CAH Stock Forecast Cardinal Health Hold 13
$80.78 Buy/Sell $58.69 -2.20%

Centene Revenue Forecast for 2022 - 2025 - 2030

Centene's Revenue has seen impressive growth In the last three years, rising from $56.69B to $118.18B – a growth of 108.47%. In the next year, analysts believe that Revenue will reach $137.01B – an increase of 15.94%. For the next nine years, the forecast is for Revenue to grow by 60.33%.

2022 Rev Forecast
$137.01B
2023 Rev Forecast
$140.68B
2024 Rev Forecast
$149.98B
2025 Rev Forecast
$149.65B
2026 Rev Forecast
$155.95B
2027 Rev Forecast
$165.64B
2028 Rev Forecast
$173.92B
2029 Rev Forecast
$181.53B
2030 Rev Forecast
$189.48B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MOH Stock Forecast Molina Healthcare Outperform 16
$339.75 Buy/Sell $328.38 8.90%
UHS Stock Forecast Universal Health Services Hold 11
$129.61 Buy/Sell $147.80 -7.41%
CHE Stock Forecast Chemed Buy 18
$522.05 Buy/Sell $565.33 10.14%

Centene Dividend per Share Forecast for 2022 - 2025 - 2030

2022 DPS Forecast
$0.00
2023 DPS Forecast
$0.00
2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ACHC Stock Forecast Acadia Healthcare Company Outperform 15
$83.32 Buy/Sell $66.90 12.22%
DVA Stock Forecast DaVita Hold 16
$74.91 Buy/Sell $124.50 0.79%
INOV Stock Forecast Inovalon Holdings - 14
$41.06 Buy/Sell $41.00 18.80%

Centene Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last three years, Centene's Free Cash Flow has seen an increase, rising from $559.00M to $3.30B. This represents a growth of 489.45%. Analysts predict that Centene's Free Cash Flow will increase in the upcoming year, reaching $4.21B. This would represent an increase of 27.88%. Over the next nine years, experts predict that Centene's Free Cash Flow will grow at a rate of 82.88%.

2022 FCF Forecast
$4.21B
2023 FCF Forecast
$4.26B
2024 FCF Forecast
$5.07B
2025 FCF Forecast
$5.03B
2026 FCF Forecast
$5.32B
2027 FCF Forecast
$5.42B
2028 FCF Forecast
$5.55B
2029 FCF Forecast
$5.76B
2030 FCF Forecast
$6.03B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
EHC Stock Forecast Encompass Health Buy 18
$57.00 Buy/Sell $65.70 10.53%
ENSG Stock Forecast The Ensign Group Outperform 18
$93.61 Buy/Sell $101.60 8.96%
LHCG Stock Forecast LHC Group Hold 14
$164.80 Buy/Sell $240.55 3.16%

Centene Net Income Forecast for 2022 - 2025 - 2030

In the last three years, Centene's Net Income has grown, moving from $900.00M to $1.35B – an increase of 49.67%. In the next year, analysts predict that Net Income will jump to $3.20B – up 137.57% from the current level. Looking ahead to nine years, experts forecast that Net Income will grow by 340.91%.

2022 NI Forecast
$3.20B
2023 NI Forecast
$3.68B
2024 NI Forecast
$4.41B
2025 NI Forecast
$4.54B
2026 NI Forecast
$4.80B
2027 NI Forecast
$5.08B
2028 NI Forecast
$5.38B
2029 NI Forecast
$5.68B
2030 NI Forecast
$5.94B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AMN Stock Forecast AMN Healthcare Services Outperform 16
$116.27 Buy/Sell $132.33 11.81%
THC Stock Forecast Tenet Healthcare Outperform 15
$44.12 Buy/Sell $82.53 35.99%
SEM Stock Forecast Select Medical Holdings Outperform 16
$23.06 Buy/Sell $47.00 56.11%

Centene EBITDA Forecast for 2022 - 2025 - 2030

Centene's EBITDA has seen growth In the last three years, going from $2.63B to $5.16B – a gain of 96.31% In the next year, analysts believe that EBITDA will reach $5.64B – an increase of 9.39%. For the next nine years, the forecast is forEBITDA to grow by 27.29%.

2022 EBITDA Forecast
$5.64B
2023 EBITDA Forecast
$6.31B
2024 EBITDA Forecast
$7.25B
2025 EBITDA Forecast
$6.30B
2026 EBITDA Forecast
$6.50B
2027 EBITDA Forecast
$6.48B
2028 EBITDA Forecast
$6.74B
2029 EBITDA Forecast
$6.59B
2030 EBITDA Forecast
$6.56B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AMED Stock Forecast Amedisys Outperform 16
$86.47 Buy/Sell $199.00 61.91%
SGRY Stock Forecast Surgery Partners Outperform 13
$23.40 Buy/Sell $0.00 175.64%
MD Stock Forecast MEDNAX Hold 12
$23.02 Buy/Sell $22.33 -4.43%

Centene EBIT Forecast for 2022 - 2025 - 2030

In the last three years, EBIT for Centene has grown by 72.65%, going from $2.13B to $3.68B. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $4.35B – an increase of 18.21%. Over the next nine years, experts anticipate that EBIT growth for Centene will be 96.98%.

2022 EBIT Forecast
$4.35B
2023 EBIT Forecast
$4.92B
2024 EBIT Forecast
$6.08B
2025 EBIT Forecast
$5.12B
2026 EBIT Forecast
$5.49B
2027 EBIT Forecast
$5.98B
2028 EBIT Forecast
$6.42B
2029 EBIT Forecast
$6.84B
2030 EBIT Forecast
$7.25B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BKD Stock Forecast Brookdale Senior Living Hold 10
$4.29 Buy/Sell $7.34 86.48%
GTS Stock Forecast Triple-S Management - 7
$35.53 Buy/Sell $19.00 -79.79%
NasdaqGS:MGLN Stock Forecast Magellan Health - 0
$0.00 Buy/Sell $95.00 0.00%

Centene EPS Price Prediction Forecast for 2022 - 2025 - 2030

Centene's EPS has seen impressive growth In the last three years, rising from $3.54 to $5.15 – a growth of 45.48%. In the next year, analysts believe that EPS will reach $5.41 – an increase of 5.05%. For the next nine years, the forecast is for EPS to grow by 172.23%.

2022 EPS Forecast
$5.41
2023 EPS Forecast
$6.31
2024 EPS Forecast
$7.65
2025 EPS Forecast
$8.50
2026 EPS Forecast
$9.38
2027 EPS Forecast
$10.36
2028 EPS Forecast
$11.49
2029 EPS Forecast
$12.75
2030 EPS Forecast
$14.02